Resorcinol is a versatile phenolic compound widely used in various personal care products. Its primary applications include:
Resorcinol, a dihydroxy benzene, is a chemical compound used extensively in cosmetic and pharmaceutical products. It is known for its antiseptic and exfoliating properties, making it beneficial for treating various skin conditions.
While resorcinol is effective, it is also a potent chemical that can cause skin irritation and sensitization in some individuals. It is important to use products containing resorcinol as directed and perform a patch test before full application. Those with sensitive skin or allergies should consult with a dermatologist prior to use.
Allergic Reactions: Resorcinol can cause allergic reactions in some individuals, leading to symptoms such as redness, itching and swelling. Individuals with suspected contact dermatitis from hair dye may consider patch testing to rule out resorcinol allergy.
Skin Irritation: Individuals with extremely sensitive skin should test a small amount of resorcinol on the skin prior to applying it on a wide surface area. If using other potent active ingredients (like retinoids or strong acids), it is advisable to consult with a dermatologist to avoid potential skin irritation or adverse interactions. Overuse or improper use of resorcinol can lead to irritant contact dermatitis and skin irritation.
Pregnant or Breastfeeding: Individuals who are pregnant or breastfeeding should avoid products containing resorcinol due to potential risks and limited safety data.
Cordero-Ramos J, Barros-Tornay R, Toledo-Pastrana T, Ferrándiz L, Calleja-Hernández MÁ, Moreno-Ramírez D. Effectiveness and safety of topical 15% resorcinol in the management of mild-to-moderate hidradenitis suppurativa: A cohort study. J Dermatol. 2022 Apr;49(4):459-462.
Katoulis A, Efthymiou O, Liakou A, Pappa G, Kanelleas A, Koumaki D, Bozi E, Sgouros D. Resorcinol 10% as a Promising Therapeutic Option for Mild Hidradenitis Suppurativa: A Prospective, Randomized, Open Study. Skin Appendage Disord. 2023 Dec;9(6):438-443.
Huh SY, Shin JW, Na JI, Huh CH, Youn SW, Park KC. The Efficacy and Safety of 4-n-butylresorcinol 0.1% Cream for the Treatment of Melasma: A Randomized Controlled Split-face Trial. Ann Dermatol. 2010 Feb;22(1):21-5.
Bae BG, Park CO, Shin H, Lee SH, Lee YS, Lee SJ, Chung KY, Lee KH, Lee JH. Salicylic acid peels versus Jessner’s solution for acne vulgaris: a comparative study. Dermatol Surg. 2013 Feb;39(2):248-53.
©2025 Club Derm. All Rights Reserved